DerrickWeisonSuMD

Oncology • Fountain Valley, CA

Hematologic Oncology

Compassionate Cancer Care Medical Group

Join to view full profile

Dr. Su is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Su's full profile

Already have an account?

Office
11180 Warner Ave.
Suite 351
Fountain Valley, CA 92708
Phone+1 714-698-0300

Fax+1 714-698-0303

Summary

Dr. Derrick Su is an oncologist in Fountain Valley, CA and Laguna Hills, CA and is affiliated with multiple hospitals in the area, including Fountain Valley Regional Hospital and Medical Center and MemorialCare, Orange Coast Memorial Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 6 years. He specializes in hematologic oncology.

Education & Training

University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2014 - 2017
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2011 - 2014
Boston University School of MedicineClass of 2011
Boston UniversityMedical Sciences, 2004 - 2007

Certifications & Licensure

CA State Medical License 2013 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

23 citations
Ruxolitinib Rechallenge Can Improve Constitutional Symptoms and Splenomegaly in Patients With Myelofibrosis: A Case Series.
Aaron T. Gerds, Derrick W. Su, Anastasia Martynova, Benjamin Pannell, Sudipto Mukherjee
Clinical Lymphoma, Myeloma & Leukemia. 2018-11-01
24 citations
Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors.
John A. Meyers, Derrick W. Su, Adam Lerner
Journal of Immunology. 2009-05-01
8 citations
Biophysical technologies for understanding circulating tumor cell biology and metastasis.
Derrick W. Su, Jorge Nieva
Translational Lung Cancer Research. 2017-08-01

Journal Articles

Larotrectinib in TRK fusion-positive, metastatic non-small cell lung cancer (NSCLC) after treatment with entrectinib in a patient with a history of coronary artery dis...
Su D et al., Current Problems in Cancer: Case Reports, 6/2022

Other Languages

Chinese (Mandarin), Spanish